These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8189055)

  • 21. Characterization of a novel bispecific antibody that mediates Fcgamma receptor type I-dependent killing of tumor-associated glycoprotein-72-expressing tumor cells.
    Russoniello C; Somasundaram C; Schlom J; Deo YM; Keler T
    Clin Cancer Res; 1998 Sep; 4(9):2237-43. PubMed ID: 9748144
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
    J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module.
    Stamova S; Cartellieri M; Feldmann A; Arndt C; Koristka S; Bartsch H; Bippes CC; Wehner R; Schmitz M; von Bonin M; Bornhäuser M; Ehninger G; Bachmann M
    Mol Immunol; 2011 Dec; 49(3):474-82. PubMed ID: 22014687
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A spacer region between the single chain antibody- and the CD3 zeta-chain domain of chimeric T cell receptor components is required for efficient ligand binding and signaling activity.
    Moritz D; Groner B
    Gene Ther; 1995 Oct; 2(8):539-46. PubMed ID: 8593604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Single chain Ig/gamma gene-redirected human T lymphocytes produce cytokines, specifically lyse tumor cells, and recycle lytic capacity.
    Weijtens ME; Willemsen RA; Valerio D; Stam K; Bolhuis RL
    J Immunol; 1996 Jul; 157(2):836-43. PubMed ID: 8752936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Construction and characterization of bispecific single-chain antibody fragments SZ-2/SZ-21 against platelet glycoprotein Ib alpha and beta3].
    Dai K; An G; Ruan C
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(21):1493-7. PubMed ID: 12509914
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improving the productivity of single-chain Fv antibody against c-Met by rearranging the order of its variable domains.
    Kim YJ; Neelamegam R; Heo MA; Edwardraja S; Paik HJ; Lee SG
    J Microbiol Biotechnol; 2008 Jun; 18(6):1186-90. PubMed ID: 18600066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel bispecific tetravalent antibody fusion protein to target costimulatory activity for T-cell activation to tumor cells overexpressing ErbB2/HER2.
    Biburger M; Weth R; Wels WS
    J Mol Biol; 2005 Mar; 346(5):1299-311. PubMed ID: 15713482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The T cell receptor gene usage by simian immunodeficiency virus gag-specific cytotoxic T lymphocytes in rhesus monkeys.
    Chen ZW; Shen L; Regan JD; Kou Z; Ghim SH; Letvin NL
    J Immunol; 1996 Feb; 156(4):1469-75. PubMed ID: 8568249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and characterization of a bispecific single-chain antibody directed against T cells and ovarian carcinoma.
    Kriangkum J; Xu B; Gervais C; Paquette D; Jacobs FA; Martin L; Suresh MR
    Hybridoma; 2000 Feb; 19(1):33-41. PubMed ID: 10768839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Construction, expression, and activity of a bivalent bispecific single-chain antibody.
    Mallender WD; Voss EW
    J Biol Chem; 1994 Jan; 269(1):199-206. PubMed ID: 8276795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single-chain bispecific Fv2 molecule produced in mammalian cells redirects lysis by activated CTL.
    Jost CR; Titus JA; Kurucz I; Segal DM
    Mol Immunol; 1996 Feb; 33(2):211-9. PubMed ID: 8649442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation and application of a fluorescein-specific single chain antibody.
    Schenk JA; Sellrie F; Böttger V; Menning A; Stöcklein WF; Micheel B
    Biochimie; 2007 Nov; 89(11):1304-11. PubMed ID: 17686564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antigen recognition and allogeneic tumor rejection in CD8+ TCR transgenic/RAG(-/-) mice.
    Manning TC; Rund LA; Gruber MM; Fallarino F; Gajewski TF; Kranz DM
    J Immunol; 1997 Nov; 159(10):4665-75. PubMed ID: 9366389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Redirecting effector T cells through their IL-2 receptors.
    Lustgarten J; Marks J; Sherman LA
    J Immunol; 1999 Jan; 162(1):359-65. PubMed ID: 9886407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity.
    Nielsen UB; Adams GP; Weiner LM; Marks JD
    Cancer Res; 2000 Nov; 60(22):6434-40. PubMed ID: 11103810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo properties of a dimeric bispecific single-chain antibody IgG-fusion protein for depletion of CCR2+ target cells in mice.
    Schneider MA; Brühl H; Wechselberger A; Cihak J; Stangassinger M; Schlöndorff D; Mack M
    Eur J Immunol; 2005 Mar; 35(3):987-95. PubMed ID: 15719369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
    Altenschmidt U; Kahl R; Moritz D; Schnierle BS; Gerstmayer B; Wels W; Groner B
    Clin Cancer Res; 1996 Jun; 2(6):1001-8. PubMed ID: 9816261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded bispecific antibody comprising of two single-chain antibodies linked to the antibody constant region.
    Natsume A; Wakitani M; Yamane-Ohnuki N; Shoji-Hosaka E; Niwa R; Uchida K; Satoh M; Shitara K
    J Biochem; 2006 Sep; 140(3):359-68. PubMed ID: 16861252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.